Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis: Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan
Open Access
- 1 July 2010
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (7) , 1011-1017
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Molecular genetics of lung cancer in people who have never smokedThe Lancet Oncology, 2008
- Lung cancer in never smokers — a different diseaseNature Reviews Cancer, 2007
- Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease EntityJournal of Clinical Oncology, 2006
- Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancerCancer, 2006
- Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung TumorsJournal of Clinical Oncology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI: Journal of the National Cancer Institute, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung CancerJAMA, 2003
- Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003